Predictive Biomarkers and Personalized Medicine Hsa-miR-31-3 p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy
暂无分享,去创建一个
S. Imbeaud | S. Rossi | S. Knuutila | P. Laurent-Puig | S. Tejpar | K. Leroy | E. Bibeau | B. Landi | J. Bachet | P. Demetter | K. Fontaine | F. Rousseau | B. Chibaudel | G. Manceau | D. L. Corre | A. Didelot | M. Vincent | Olivier Bouch | J. Laethem | NedaMosakhani | VirinderSarhadi | Thierry Andr